Browse EX-10 agreements

RESTRICTED STOCK UNIT AGREEMENT

 

 

Participant: Ramesh Srinivasan

 

Grant Date: June 18, 2026

 

Restricted Stock Units: 78,269

 

THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”) is entered into as of the Grant Date set forth above by and between Agilysys, Inc., a Delaware corporation (the “Company”), and the Participant set forth above (“you” or the “Participant”).

 

Award.

(a)

The Company hereby grants you on the Grant Date an award (the “Award”) consisting of the aggregate number of Restricted Stock Units set forth above (the “Restricted Stock Units”). Each Restricted Stock Unit represents the right to receive one share of Common Stock, subject to the terms and conditions set forth in this Agreement and the Agilysys, Inc. 2024 Equity Incentive Plan, as amended from time to time (the “Plan”). This Award is granted to you in consideration of the services you will render to the Company and is made pursuant to the Plan.

(b)

…

AMENDED AND RESTATED EMPLOYMENT AGREEMENT

 

This Amended and Restated Employment Agreement (“Agreement”) is made between Agilysys, Inc. (“Agilysys” or the “Company”) and Ramesh Srinivasan (“you”) and is effective June 18, 2026 (the “Effective Date”). Except with respect to any documents related to previously granted equity awards, this Agreement supersedes in all respects all prior agreements between you and the Company regarding the subject matter herein, including without limitation (i) the employment agreement between you and the Company dated March 10, 2023 (the “Prior Employment Agreement”), and (ii) any other offer letter, employment agreement or severance agreement.

 

…

FOURTH AMENDMENT TO

SECOND AMENDED AND RESTATED CREDIT AGREEMENT

 

THIS FOURTH AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT(this “Amendment”) dated and effective as of June 17, 2026 (the “Execution Date”) is entered into by and among TOTALSTONE, LLC, a Delaware limited liability company (“TotalStone”), NORTHEAST MASONRY DISTRIBUTORS, LLC, a Delaware limited liability company (“Northeast”), TOTALSTONE PROPERTIES, LLC, a Delaware limited liability company (“Properties”, and together with TotalStone and Northeast, individually or collectively, “Borrower”), STREAM FINANCE, LLC, a Delaware limited liability company (in its individual capacity, “Stream”), as agent for the Lenders (as defined below) (in such capacity, the “Agent”), and the Lenders signatory hereto.

…

EXECUTION COPY

 

SIXTEENTH AMENDMENT TO REVOLVING CREDIT, TERM LOAN

AND SECURITY AGREEMENT

 

THIS SIXTEENTH AMENDMENT TO REVOLVING CREDIT, TERM LOAN AND SECURITY AGREEMENT (this “Sixteenth Amendment”) is entered into as of June 11, 2026, as defined below, by and among TOTALSTONE, LLC, a Delaware limited liability company (“TotalStone”), NORTHEAST MASONRY DISTRIBUTORS, LLC (f/k/a NEM Purchaser, LLC), a Delaware limited liability company (“Northeast”), TOTALSTONE PROPERTIES, LLC, a Delaware limited liability company (“Properties”), CS PURCHASE HOLDINGS LLC, a Delaware limited liability company (“CS Purchase”), CAROLINA STONE HOLDINGS, LLC, a Delaware limited liability company (“Carolina Holdings”), and CAROLINA STONE DISTRIBUTORS, LLC, a Delaware limited liability company (“Carolina Distributors,” collectively with CS Purchase, Carolina Holdings (“CSP” , and collectively with TotalStone, Northeast, Properties, CS Purchase, and Carolina Holdings, the “Borrower”), and BEACON BANK & TRUST (successor by merger to BERKSHIRE BANK), a Massachus

…

FIRST AMENDMENT TO THE CAPSTONE HOLDING CORP. 2025 STOCK INCENTIVE PLAN

 

Effective June 18, 2026

 

This First Amendment (this “Amendment”) to the Capstone Holding Corp. 2025 Stock Incentive Plan (the “Plan”), which was approved by the stockholders of Capstone Holding Corp. (the “Company”) on November 18, 2025, is made and adopted by the Board of Directors of the Company.

 

RECITALS

 

WHEREAS, the Board of Directors has determined that it is in the best interests of the Company and its stockholders to amend the Plan to increase the maximum aggregate number of shares of Common Stock available for awards; and

WHEREAS, the holders of the Company’s Series B Preferred Stock have consented to this Amendment in accordance with Section 1.5(v) of the Certificate of Designation of the Series B Preferred Stock.

 

AMENDMENT

…

Document

THIRD AMENDMENT TO SENIOR SECURED TERM LOAN AGREEMENT AND LIMITED WAIVER TO PURCHASE AND SALE AGREEMENT

THIRD AMENDMENT TO SENIOR SECURED TERM LOAN AGREEMENT AND LIMITED WAIVER TO PURCHASE AND SALE AGREEMENT (this “Third Amendment”), dated as of June 22, 2026, is by and among Sable Offshore Corp., a Delaware corporation (the “Borrower” or “Purchaser”), Pacific Offshore Pipeline Company (“POPC”), Pacific Pipeline Company (“PPC”), Sable Ocean America LLC (“Ocean America” and, together with POPC and PPC, the “Guarantors” and each, a “Guarantor”), Exxon Mobil Corporation, a New Jersey corporation, as lender (the “Lender” or “EMC”), Mobil Pacific Pipeline Company, a Delaware corporation (“MPPC”, and together with EMC, the “Sellers” and each, a “Seller”), and Alter Domus Products Corp., as administrative agent for the benefit of the Secured Parties (in such capacity, the “Administrative Agent”). The Sellers and the Purchaser are sometimes hereinafter referred to individually as a “PSA Party” and collectively as the “PSA Parties”. Capitalized terms used and not otherwise defined

…

Exhibit 10.30b

 

CREDITLINE PROMISSORY NOTE

(Amended and Restated as of June 1, 2026)

 

Dated: June 1, 2026

FOR VALUE RECEIVED, on June 1, 2026, the undersigned Nutriband Inc., 121 South Orange Street, Suite 1500, Orlando, Florida 32801(” Borrower”), promises to pay to the order of TII JET SERVICES,LDA, or order (“Lender”), with offices at Rua das Ladeiras 5, Porto Santo, 9400-131 Portugal, the principal sum of Five Million Dollars ($5,000,000), or so much thereof as is advanced hereunder (“Advances”), with interest at the rate of Seven (7%) Percent per annum. Borrower shall make payments of interest accrued on the outstanding amount of this credit line note (the “Note” or this “Credit Line”) as of each calendar year end during the term of the Credit Line, commencing with June 1, 2026. Such payments of accrued interest shall be paid within 30 days of the respective December 31 accrual amount determination date and shall be accompanied by a Compliance Certificate, properly completed and executed by the Borrower, indicating that the Borrower is in compliance with all cove

…

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

UNSECURED PROMISSORY NOTE

 

$[_____________]

__________, 2026

…

EXCHANGE AGREEMENT

 

THIS EXCHANGE AGREEMENT (this “Agreement”) is made as of June 16, 2026, by and among the undersigned holders (each, a “Holder” and, together, the “Holders”) and Olenox Industries Inc., a Delaware Corporation (the “Company”).

 

WHEREAS, as of the date hereof, the Holders collectively own all of the Series D Preferred Stock (the “Existing Preferred”) of the Company.

 

WHEREAS, the Holders desire to surrender the Existing Preferred in exchange for an equal number of shares of Series E Preferred Stock (the “New Preferred”) of the Company;

 

WHEREAS, the Company desires to accept the surrender of the Existing Preferred in exchange for the issuance of the New Preferred in accordance with the terms of this Agreement.

 

ACCORDINGLY, the parties agree as follows:

…

FOURTH AMENDMENT TO THE

FIRST CITIZENS COMMUNITY BANK

SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN

 

This Fourth Amendment (this “Amendment”) to the First Citizens Community Bank Supplemental Executive Retirement Plan, as amended (the “SERP”), is effective as of June 16, 2026.

 

W I T N E S S E T H:

 

WHEREAS, First Citizens Community Bank (the “Bank”) maintains the SERP for the benefit of certain senior officers; and

 

WHEREAS, the Board of Directors of the Bank resolved to amend the SERP to make certain modifications, effective as of June 16, 2026.

 

NOW, THEREFORE, the SERP is hereby amended as follows:

 

1. Appendix A to the SERP is deleted in its entirety, to be replaced by the Appendix A attached to this Amendment.

2. Appendix B to the SERP is deleted in its entirety, to be replaced by the Appendix B attached to this Amendment.

 

 

IN WITNESS WHEREOF, the Bank has caused this Amendment to be executed by its duly authorized officer on June 16, 2026.

 

 

By: Gina Marie Boor

Title: Corporate Secretary

Signature: /s/ Gina Marie Boor

…

---

Exhibit 10.2

LICENSE AGREEMENT

 

This License Agreement (“Agreement”) is entered into and effective as of June 17, 2026 (the “Effective Date”), by and between Paragon Therapeutics, Inc., a corporation organized under the laws of the State of Delaware (“Paragon”), having its principal place of business at 221 Crescent Street, Building 17, Suite 102B, Waltham, MA 02453, and Apogee Therapeutics, Inc. (“Apogee”), a corporation organized under the laws of the State of Delaware, having its principal place of business at 221 Crescent Street, Building 17, Suite 102B, Waltham, MA 02453.  Paragon and Apogee are also referred to herein individually as a “Party”, or collectively as the “Parties.”

 

RECITALS

 

Whereas, Paragon has developed a proprietary platform technology for the discovery and development of antibodies against therapeutically relevant targets;

…

---

Exhibit 10.1

ANTIBODY DISCOVERY AGREEMENT

This Antibody Discovery Agreement (“Agreement”) is entered into and effective as of June 17, 2026 (the “Effective Date”), by and between Paragon Therapeutics, Inc., a Delaware corporation (“Paragon”), and Apogee Therapeutics, Inc., a Delaware corporation (“Apogee”).  Paragon and Apogee are also referred to herein individually as a “Party”, or collectively as the “Parties.”

Recitals

Whereas, Paragon has developed a proprietary platform technology for the discovery and development of antibodies against therapeutically relevant targets;

Whereas, Paragon has been performing and may continue to perform certain antibody discovery and development activities for Apogee to discover, generate, identify and characterize monospecific antibody candidates Directed To the Licensed Target, all on the terms and subject to the conditions set forth in this Agreement; and

…